Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2009, Vol. 14 ›› Issue (10): 1178-1182.
Previous Articles Next Articles
MAO Jie1, XU Shan-shui1, SHEN Li-li2, WANG Xuan-zhi1
Received:
2009-06-11
Revised:
2009-08-11
Published:
2020-10-29
CLC Number:
MAO Jie, XU Shan-shui, SHEN Li-li, WANG Xuan-zhi. Advances in the studies on the anti-tumor effect and mechanism of baicalein[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(10): 1178-1182.
[1] Ishimaru K, Nishikawa K, Omoto T, et al.Two flavone 2' -glucosides from Scutellaria baicalensis[J].Phytochemistry, 1995, 40(1):279-281. [2] Cherng JM, Shieh DE, Chiang W, et al.Chemopreventive effects of minor dietary constituents in common foods on human cancer cells[J].Biosci Biotechnol Biochem, 2007, 71(6):1500-1504. [3] Tong WG, Ding XZ, Witt RC, et al.Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway[J].Mol Cancer Ther, 2002, 1(11):929-935. [4] Ikemoto S, Sugimura K, Kuratukuri K, et al.Antitumor effects of lipoxygenase inhibitors on murine bladder cancer cell line (MBT-2)[J].Anticancer Res, 2004, 24(2B): 733-736. [5] Chen CH, Huang LL, Huang CC, et al.Baicalein, a novel apoptotic agent for hepatoma cell lines:a potential medicine for hepatoma[J].Nutr Cancer, 2000, 38(2): 287-295. [6] Piao YS, Du YC, Oshima H, et al.Platelet-type 12-lipoxygenase accelerates tumor promotion of mouse epidermal cells through enhancement of cloning efficiency[J]. Carcinogenesis, 2008, 29(2):440-447. [7] Lee MJ, Wang CJ, Tsai YY, et al.Inhibitory effect of 12-O-tetradecanoy lphorbol-13-acetate caused tumor promotion in benzo[a] pyrene-initiated Cd-1 mouse skin by baicalein[J].Nutr Cancer, 1999, 34(2):185-191. [8] Fǜrstenberger G, Krieg P, Mǜller-Decker K, et al.What are cyclooxygenases and lipoxygenases doing in the driver' s seat of carcinogenesis[J] ? Int J Cancer, 2006, 15119(10):2247-2254. [9] Yoshimura R, Matsuyama M, Tsuchida K, et al.Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors[J].J Urol, 2003, 170(5):1994-1999. [10] Yoshimura R, Inoue K, Kawahito Y, et al.Expression of 12-lipoxygenase in human renal cell carcinoma and growth prevention by its inhibitor[J].Int J Mol Med, 2004, 13(1):41-46. [11] Wartenberg M, Budde P, De Mareé s M, et al.Inhibition of tumor-induced angiogenesis and matrix-metalloproteinase expression in confrontation cultures of embryoid bodies and tumor spheroids by plant ingredients used in traditional chinese medicine[J].Lab Invest, 2003, 83(1):87-98. [12] Miocinovic R, McCabe NP, Keck RW, et al.In vivo and in vitro effect of baicalein on human prostate cancer cells [J].Int J Oncol, 2005, 26(1):241-246. [13] Nie D, Krishnamoorthy S, Jin R, et al.Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells[J].J Biol Chem, 2006, 281(27):18601-18609. [14] Roy MK, Nakahara K, Na TV, et al.Baicalein, a flavonoid extracted from a methanolic extract of Oroxylum indicum inhibits proliferation of a cancer cell line in vitro via induction of apoptosis[J].Pharmazie, 2007, 62(2):149-153. [15] Chao JI, Su WC, Liu HF.Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT[J].Mol Cancer Ther, 2007, 6(11):3039-3048. [16] Leung HW, Yang WH, Lai MY, et al.Inhibition of 12- lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis[J].Food Chem Toxicol, 2007, 45(3):403-411. [17] Li QB, You Y, Chen ZC, et al.Role of Baicalein in the regulation of proliferation and apoptosis in human myeloma RPMI8226 cells[J].Chin Med J (Engl), 2006, 119(11):948-952. [18] Lee HZ, Leung HW, Lai MY, et al.Baicalein induced cell cycle arrest and apoptosis in human lung squamous carcinoma CH27 cells [J].Anticancer Res, 2005, 25(2A):959-964. [19] Kovarí ková M, Hofmanová J, Soucek K, et al.The effects of TNF-alpha and inhibitors of arachidonic acid metabolism on human colon HT-29 cells depend on differentiation status[J].Differentiation, 2004, 72(1):23-31. [20] Lin YT, Yang JS, Lin HJ, et al.Baicalein induces apoptosis in SCC-4 human tongue cancer cells via a Ca2+-dependent mitochondrial pathway [J].In Vivo, 2007, 21(6):1053-1058. [21] Pidgeon GP, Kandouz M, Meram A, et al.Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells [J]. Cancer Res, 2002, 62(9):2721-2727. [22] Ma Z, Otsuyama K, Liu S, et al.Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells[J].Blood, 2005, 105(8):3312-3318. [23] Michalik L, Desvergne B, Wahli W.Peroxisome-proliferator- activated receptors and cancers:complex stories[J].23] Michalik L, Desvergne B, Wahli W.Peroxisome-proliferator- activated receptors and cancers:complex stories[J]. Nat Rev Cancer, 2004, 4(1):61-70. [24] Otsuyama KI, Ma Z, Abroun S, et al.PPARbeta-mediated growth suppression of baicalein and dexamethasone in human myeloma cells[J].Leukemia, 2007, 21(1):187-190. [25] Dearth RK, Cui X, Kim HJ, et al.Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2[J].Cell Cycle, 2007, 6(6): 705-713. [26] Lin CW, Yang LY, Shen SC, et al.IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells[J].J Cell Physiol, 2007, 212(3):666-674. [27] Bonham M, Posakony J, Coleman I, et al.Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma[J].Clin Cancer Res, 2005, 11(10):3905-3914. [28] Chen S, Ruan Q, Bedner E, et al.Effects of the flavonoid baicalin and its metabolite baicalein on androgen receptor expression, cell cycle progression and apoptosis of prostate cancer cell lines[J].Cell Prolif, 2001, 34(5): 293-304. [29] Po LS, Chen ZY, Tsang DS, et al.Baicalein and genistein display differential actions on estrogen receptor (ER) transactivation and apoptosis in MCF-7 cells[J]. Cancer Lett, 2002, 187(1/2):33-40. [30] Gǜnther S, Ruhe C, Derikito MG, et al.Polyphenols prevent cell shedding from mouse mammary cancer spheroids and inhibit cancer cell invasion in confrontation cultures derived from embryonic stem cells[J].Cancer Lett, 2007, 250(1):25-35. [31] Ding XZ, Kuszynski CA, El-Metwally TH, et al.Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells[J].Biochem Biophys Res Commun, 1999, 266(2):392-399. [32] Nie D, Nemeth J, Qiao Y, et al.Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase[J].Clin Exp Metastasis, 2003, 20(7):657-663. [33] Lee WJ, Wu LF, Chen WK, et al.Inhibitory effect of luteolin on hepatocyte growth factor scatter factor-induced HepG2 cell invasion involving both MAPK ERKs and PI3K-Akt pathways[J].Chem Biol Interact, 2006, 160(2):123-133. [34] 徐珊, 罗莉, 朱利群, 等.4′-甲醚-黄芩素对绒癌耐药细胞株多药耐药性的逆转作用研究[J].生物化学与生物物理进展, 2006, 33(11):1061-1073. [35] Lee Y, Yeo H, Liu SH, et al.Increased anti-P-gly coprotein activity of baicalein by alkylation on the A ring[J].J Med Chem, 2004, 47(22):5555-5566. |
[1] | HE Lihua, ZHU Xiuzhi, JIANG Yizhou. Research progress on immunotherapy for triple-negative breast cancer [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 842-853. |
[2] | LI Shuang, HAN Shuzhen, DAI Yuting, XIU Minghui, DU Xianqin, HE Jianzheng, LIN Xingyao. Progress in the prevention and treatment of traditional Chinese medicine based on the mechanism of intestinal injury of various chemotherapy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 583-593. |
[3] | CAO Fang, QIN Kairong, ZHENG Guoshuang, ZHAO Dewei. Exploring the intervention mechanism of Ginkgo biloba for steroid-induced necrosis of the femoral head based on network pharmacology [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 266-275. |
[4] | ZHANG Li, LIN Xingyao, SHANG Yun, WANG Qiang. Progress on the pathological mechanism and treatment of frostbite [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 347-354. |
[5] | LI Xinyu, HUANG Xin. State of clinical application of meloxicam [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 189-197. |
[6] | WANG Jian, SUN Yongdong, ZHOU Xingwei, LIU Lei, CHEN Long, TONG Xingke, ZHU Jiali. Baicalein promotes laryngeal cancer cell death and inhibits invasion via miR-125b-5p/IRF4 axis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1209-1218. |
[7] | CHEN Yulin, JIANG Hugang, WANG Xinqiang, LIU Kai, LI Yingdong, AN Tao, ZHAO Xinke. Effects and mechanism of Ginseng Yixin granules (QSYXG) for heart failure with preserved ejection fraction based on the network pharmacology and molecular docking strategy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1081-1092. |
[8] | LIU Dan, LIU Ming, JIN Liangyou, PAN Juan, XIN Haoru, LIU Mengyuan, LI Xin, ZHENG Kun, FENG Xiaoling. Research progress on the antitumor activity of costunolide [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1168-1176. |
[9] | SHAO Mingkun, LIU Rong, SUN Pin, GUAN Shui, LIAO Bingcan, LI Sha, CONG Tao, LIANG Kai, MA Hui, SUN Changkai. Human body networks mechanisms of melatonin and its clinical applications [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1031-1040. |
[10] | ZHANG Wei, WANG Yingbin, CAO Lu, LIU Yan, ZHANG Li, LIU Jieting. Research progress of autophagy in intestinal ischemia-reperfusion injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1061-1066. |
[11] | WANG Liang, ZHANG Hulin, WANG Xiaomin, YANG Chaoqiang, WANG Yican, LAI Xueqian. Research progress on the mechanism of iron overload in the occurrence and development of osteoarthritis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1075-1080. |
[12] | HAN Xiaoxia, LENG Yufang, LV Xingjiao, HOU Xiaoyu, CAO Xuefen, Janvier NIBARUTA. Research progress on the role and mechanism of irisin in organ ischemia/reperfusion injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 886-891. |
[13] | DU Jie, ZHAO Tingting, WANG Dalong, CHEN Xiaodong, LIU Kexin, WU Jingjing. Role and research progress of CYP46A1 in neurodegenerative diseases [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 925-935. |
[14] | LI Miao, YU Qinwei, JIANG Zhenzhou, ZHANG Luyong, . Regulatory mechanism of LDLR and research progress of its related diseases and drugs [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 946-954. |
[15] | DING Hao, GAO Zhenhua, ZHENG Yun. Research progress of microRNA in diagnosis and treatment of prostate cancer [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 696-708. |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 449
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 239
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||